Paul A. Offit, an infectious disease specialist, discusses the costs of not vaccinating children for fear of autism.
Michael G. Fitzsimons, head of the drug-testing program at the Massachusetts General Hospital’s Department of Anesthesia and Critical Care, discusses preventing fallout from addicted physicians.
Art and message merged in twentieth-century posters, raising the alarm about contagions from TB to AIDS.
Ordinarily resistant to economic ills, health care this time is suffering too. Poor and uninsured patients are most at risk.
They work without employees, fancy offices or big incomes. But back-to-basics doctors cite one elusive perk: satisfaction.
Will consumers continue to have the power to question a drug’s safety?
Emergency room jam-ups threaten patients, inflate costs and disrupt hospital operations. Small fixes might solve this big problem.
Billing for care now costs almost a third as much as providing it. It’s time to cut the paperwork.
Pharmacists propose a third category of drugs—“behind the counter”—which they, not doctors, would prescribe.
Point: Yes, they are key in the nation’s efforts to develop a value-driven health care system. Counterpoint: No, because the wrong kind of measurements can do more harm than good.
No Articles Found.
Stay on the frontiers of medicine